Skip to main content

SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium

Written by Customer Service on . Posted in Mergers And Acquisitions.

TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRx Health” or the “Company”), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia.

The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements.

Following the closing of this potential transaction, the Company intends to adopt a new corporate name and new ticker symbol, reflecting its expanded mission to combine hard-asset energy royalties to capitalize on surging AI & data center power demand.

Positioned for the Future of Energy
The acquisition would deliver a diversified portfolio of 18 uranium royalties across premier exploration and development projects in the Americas, providing long-term leverage to a commodity at the center of the global clean energy transition. Key royalties include:

  1. 1.0% NSR on the Berlin Project in Colombia
  2. 2.0% NSR on Mountain Lake in Canada
  3. 1.0% NSR on non-Mountain Lake properties in Nunavut
  4. 2.0% NSR on Laguna Salada in Argentina
  5. 1.0% NSR on Huemul in Argentina
  6. 2.0% NSR on Anna Lake & B Zone in Canada
  7. 2.0% NSR on Larocque Lake in Canada
  8. 2.0% NSR on Bell Lake in Canada
  9. 2.0% NSR on Flat Rock Island in Canada
  10. 2.0% NSR on Shea Creek in Canada
  11. 2.0% NSR on Shasko Bay in Canada
  12. 2.0% NSR on Pine South Channel in Canada
  13. 2.0% NSR on PLS Regional in Canada
  14. 2.0% NSR on Kelic Lake in Canada
  15. 2.0% NSR on Cable Bay (Ursa) in Canada
  16. 2.0% NSR on Virgin River
  17. 2.0% NSR on Lazy Edward Bay in Canada
  18. 2.0% NSR on Perpete Lake in Canada

These royalties represent a diversified exposure to uranium development projects across key jurisdictions in North and rest of world, offering long-term upside potential as the global demand for nuclear energy and uranium increases. Partners on these royalties include world class uranium operators such as Cameco, UEC, Denison Mines, ISO Energy, and others.

Tapping Into Surging AI & Data Center Power Demand
Nuclear energy with its 24/7 baseload power and near-zero carbon emissions is increasingly being adopted by major tech companies to secure reliable power for AI operations. Royal Uranium’s strategy is to capitalize on the remarkable growth in energy demand from AI and hyperscale data centers by building royalty portfolio which offers highly strategic exposure to a tightening market with multi-decade growth potential. Global data center power consumption is forecast to increase by more than 160% by 2030, with AI-related demand alone projected to add 200 TWh annually by the end of the decade.

About SRx Health Solutions, Inc.
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical patient care initiatives aimed to improve the wellness of Canadians. For more information on SRx Health Solutions Inc., please visit www.srxhealth.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.